Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes

ClinicalTrials.gov ID: NCT02460978

Public ClinicalTrials.gov record NCT02460978. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 9:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Dapagliflozin as an Add-on to Insulin Therapy in Subjects With Type 1 Diabetes Mellitus - Study Two

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine if adding dapagliflozin to insulin is a safe and effective therapy to improve glycemic control in patients with type 1 diabetes.

Study identification

NCT ID
NCT02460978
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
815 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 8, 2015 (Actual)
Primary completion
Sep 2, 2017 (Actual)
Completion
Apr 18, 2018 (Actual)
Last update posted
Mar 5, 2019

2015 – 2018

United States locations

U.S. sites
47
U.S. states
19
U.S. cities
43
Facility City State ZIP Site status
Research Site Concord California 94520 —
Research Site Fresno California 93720 —
Research Site Los Angeles California 90057 —
Research Site Orange California 92868 —
Research Site San Mateo California 94401 —
Research Site San Ramon California 94583 —
Research Site Walnut Creek California 94598 —
Research Site Golden Colorado 80401 —
Research Site Newark Delaware 19713 —
Research Site Bradenton Florida 34201 —
Research Site Clearwater Florida 33756 —
Research Site Fort Lauderdale Florida 33312 —
Research Site Jacksonville Florida 32216 —
Research Site Miami Florida 33156 —
Research Site Miami Springs Florida 33166 —
Research Site St. Petersburg Florida 33709 —
Research Site Tampa Florida 33634 —
Research Site Atlanta Georgia 30308 —
Research Site Atlanta Georgia 30318 —
Research Site Roswell Georgia 30076 —
Research Site Chicago Illinois 60607 —
Research Site Chicago Illinois 60611 —
Research Site Des Moines Iowa 50314 —
Research Site Overland Park Kansas 66209 —
Research Site Lexington Kentucky 40502 —
Research Site Lexington Kentucky 40503 —
Research Site Kalamazoo Michigan 49008 —
Research Site Edina Minnesota 55435 —
Research Site Jefferson City Missouri 65109 —
Research Site St Louis Missouri 63110 —
Research Site Reno Nevada 89511 —
Research Site Albuquerque New Mexico 87109 —
Research Site Albany New York 12208 —
Research Site Flushing New York 11355 —
Research Site Mineola New York 11501 —
Research Site New Hyde Park New York 11042 —
Research Site New York New York 10029 —
Research Site Philadelphia Pennsylvania 19107-4824 —
Research Site Amarillo Texas 79106 —
Research Site Austin Texas 78731 —
Research Site Dallas Texas 75231 —
Research Site Edinburg Texas 78539 —
Research Site Mesquite Texas 74194 —
Research Site San Antonio Texas 78229 —
Research Site San Antonio Texas 78258 —
Research Site Bennington Vermont 05201 —
Research Site Federal Way Washington 98003 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 89 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02460978, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 5, 2019 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02460978 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →